ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,085,000 | -49.6% | 52,128 | -20.6% | 0.00% | 0.0% |
| Q3 2016 | $2,151,000 | +46.8% | 65,629 | +11.8% | 0.00% | 0.0% |
| Q2 2016 | $1,465,000 | -15.1% | 58,713 | -16.7% | 0.00% | 0.0% |
| Q1 2016 | $1,726,000 | -82.3% | 70,496 | -76.1% | 0.00% | -80.0% |
| Q4 2015 | $9,757,000 | -0.7% | 295,378 | -1.5% | 0.01% | -16.7% |
| Q3 2015 | $9,825,000 | -45.0% | 299,901 | -11.0% | 0.01% | -40.0% |
| Q2 2015 | $17,848,000 | +93.4% | 336,924 | +5.4% | 0.01% | +100.0% |
| Q1 2015 | $9,229,000 | +119.3% | 319,798 | +121.0% | 0.01% | +150.0% |
| Q4 2014 | $4,209,000 | +119.7% | 144,700 | -4.2% | 0.00% | +100.0% |
| Q3 2014 | $1,916,000 | -43.8% | 151,086 | -11.0% | 0.00% | -50.0% |
| Q2 2014 | $3,408,000 | – | 169,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |